SMAD2 and glioblastoma: Even though SMAD2 and SMAD3 are reported to be substrates for MPS1 [26, 27], we did not notice significant inhibition of phosphorylation of SMAD2 in GBM cells after MPS1 inhibition (Figure 6), contrary to earlier reports.